Targeted chemotherapy for parasite infestations in rural black preschool children

M Taylor1, G Pillai, J D Kvalsvig

  • 1Department of Pharmacology, University of Durban-Westville.

Insights

Targeted chemotherapy significantly reduced parasitic infections in rural South African preschool children. Regular deworming is effective, but improved sanitation is crucial for long-term parasite control.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • Parasitic infections are a significant health burden in rural communities.
  • Preschool children are particularly vulnerable to the effects of these infections.

Purpose of the Study:

  • To evaluate the effectiveness of targeted chemotherapy in reducing parasite prevalence among rural black preschool children.
  • To assess reinfestation rates following treatment.

Main Methods:

  • A before/after trial was conducted over 21 weeks in rural KwaZulu/Natal.
  • Stool and urine samples were analyzed from 200 children (4-6 years old).
  • Targeted chemotherapy included albendazole, praziquantel, and metronidazole, administered twice.

Main Results:

  • Significant reductions in Ascaris lumbricoides, Trichuris trichiura, and Necator americanus were observed post-treatment.
  • Reinfestation rates at 12 weeks varied by parasite: 16% (A. lumbricoides), 33% (T. trichiura), 24% (Giardia lamblia), and 3% (N. americanus).
  • No reinfestation occurred for Schistosoma haematobium, Hymenolepsis, or Taenia species.

Conclusions:

  • Targeted chemotherapy at regular intervals can effectively lower parasite prevalence in children.
  • Sustainable parasite control requires concurrent improvements in clean water and sanitation infrastructure for rural South African communities.
Abstract

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...